About Virocan Therapeutics Private Limited
Data last updated:
Virocan Therapeutics Private Limited is a private limited company based in Guntur, Andhra Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 18 August 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24239AP2005PTC047169.
The company has an authorised share capital of ₹49 Lakh and a paid-up capital of ₹49 Lakh. It is led by directors including Donald Willard Weaver and Jose Edson Silva Pontes.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Guntur, Andhra Pradesh.
The company is associated with 1 brand: Virocan Therapeutics.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website virocan.com.
Company details
Contact details
Virocan Therapeutics Private Limited's registered office is in Guntur, Andhra Pradesh. Its website is virocan.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressNH – 5 Edulapalem, Prathipadu, Guntur, Andhra Pradesh, India – 522019
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Virocan Therapeutics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Virocan Therapeutics operates one associated brand: Virocan Therapeutics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Biotechnology research and drug discovery focused on cancer and related diseases. | virocan.com |
Financials of Virocan Therapeutics Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Virocan Therapeutics Private Limited, buy the company report.
Board of directors of Virocan Therapeutics Private Limited
Virocan Therapeutics has 4 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Donald Willard Weaver | Director | 16 Apr 2012 | 14 Years 6 Months | Current |
| Jose Edson Silva Pontes | Director | 20 Jul 2014 | 12 Years 3 Months | Current |
| Sreenivasa Rao Batchu Also directs: BRD Agro Products Private Limited | Director | 21 Aug 2025 | 1 Years 2 Months | Current |
| Rajesh Dachepalli Also directs: Dayspring Therapeutics Private Limited | Manager | 25 Sep 2013 | 13 Years 0 Months | Current |
Shareholding
The shareholding of Virocan Therapeutics Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Virocan Therapeutics Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Virocan Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Virocan Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Virocan Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Virocan Therapeutics Private Limited has 15 board changes on record since 2012: 4 appointments and 11 cessations. The latest: Sreenivasa Rao Batchu was appointed as Director on 21 Aug 2025.
6 earlier events are in the company report.
Frequently asked questions
Virocan Therapeutics is an active private limited company based in Guntur, Andhra Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 18 August 2005 (21+ years old) and is registered under CIN U24239AP2005PTC047169.
Virocan Therapeutics has 4 current directors:
- Donald Willard Weaver - Director
- Jose Edson Silva Pontes - Director
- Sreenivasa Rao Batchu - Director
- Rajesh Dachepalli - Manager
The latest financial statements of Virocan Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Virocan Therapeutics is U24239AP2005PTC047169. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Virocan Therapeutics was incorporated on 18 August 2005, making it 21+ years old. It is registered with the Registrar of Companies, Vijayawada.
Sreenivasa Rao Batchu was appointed as Director on 21 Aug 2025. David Ellis ceased to be Director on 28 Mar 2019. Kambhampati Laxmi Kantha Rao ceased to be Director on 14 Sep 2018. Virocan Therapeutics has 15 board changes on record in total.
Virocan Therapeutics can be reached through the website virocan.com. Its registered office is in Guntur, Andhra Pradesh, India.
The registered office of Virocan Therapeutics is at NH – 5 Edulapalem, Prathipadu, Guntur, Andhra Pradesh, India – 522019.
Virocan Therapeutics operates in the chemicals industry, in the chemical products segment.
The compliance status of Virocan Therapeutics is compliant as of 05 September 2026. The company is actively filing with the Registrar of Companies.